ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Oncocyte Corporation

Oncocyte Corporation (OCX)

2,01
-0,04
(-1,95%)
Fermé 09 Février 10:00PM
1,97
-0,04
(-1,99%)
Après les heures de négociation: 1:59AM
Quarter End Déc 2022Mar 2023Juin 2023Sept 2023Déc 2023Mar 2024Juin 2024Sept 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Actif total 100,09M82,8M87,54M81,59M74,89M70,97M74,72M70,22M
Total de l'actif circulant 25,54M15,65M20,98M16,92M10,7M6,54M9,97M4,79M
Trésorerie et équivalents 19,99M11,8M17,37M13,78M9,43M5,58M9,26M3,36M
Total des actifs non courants 74,56M67,15M66,52M64,67M64,19M64,44M64,75M65,42M
Total des passifs 60,5M39,34M39,22M39,1M49,3M54,05M52,02M60,51M
Total des passifs courants 12,11M9,43M7,67M8,03M7,19M8,33M7,2M9,09M
Total des passifs non courants 48,39M29,91M31,55M31,07M42,1M45,73M44,82M51,42M
Capitaux propres ordinaire 294,93M295,53M309,54M310M310,3M310,55M326,2M326,68M
Bénéfices non distribués -260,68M-257,64M-265,98M-272,47M-289,88M-299,01M-303,54M-317,03M
Fin d'année 31 Décembre 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Actif total 14,45M10,22M9,52M39,86M55,42M159,56M100,09M74,89M
Total de l'actif circulant 12,7M8,53M8,64M22,96M9,23M39,14M25,54M10,7M
Trésorerie et équivalents 10,17M7,6M8,03M22,07M7,14M35,61M19,99M9,43M
Total des actifs non courants 9,86M4,4M3,42M30,84M33,48M65,22M34,29M20,47M
Total des passifs 4,59M5,81M6,1M9,02M21,94M94,35M60,5M49,3M
Total des passifs courants 4,28M4,45M5,56M4,44M9M14,12M12,11M7,19M
Total des passifs non courants 620k2,72M1,07M6,54M14,67M80,34M48,39M42,1M
Total des capitaux propres 9,86M4,4M3,42M30,84M33,48M65,22M34,29M20,47M
Capitaux propres ordinaire 45,82M59,97M74,74M124,58M157,16M252,95M294,93M310,3M
Bénéfices non distribués -35,3M-54,68M-71,32M-93,75M-123,68M-187,77M-260,68M-289,88M

Dernières Valeurs Consultées